Bellicum Pharmaceuticals, Inc.
BLCM · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,973 | -$9,705 | -$7,722 | -$112,477 |
| Dep. & Amort. | $11 | $138 | $1,874 | $8,506 |
| Deferred Tax | $0 | -$14,648 | -$48,633 | $24,279 |
| Stock-Based Comp. | $2,609 | $3,439 | $5,031 | $7,338 |
| Change in WC | -$1,466 | -$2,353 | -$8,164 | -$6,904 |
| Other Non-Cash | -$1,964 | $23 | $964 | $1,689 |
| Operating Cash Flow | -$25,783 | -$23,106 | -$56,650 | -$77,569 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$21 | -$7 | -$625 | -$522 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $49,379 |
| Other Inv. Act. | $0 | $900 | $14,705 | $0 |
| Investing Cash Flow | -$21 | $893 | $14,080 | $48,857 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $22,901 | $8,977 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $32,873 | -$14,238 | $74,088 |
| Financing Cash Flow | $0 | $32,873 | -$14,238 | $74,088 |
| Forex Effect | -$16 | $1 | -$12 | -$228 |
| Net Chg. in Cash | -$25,820 | $10,661 | -$56,820 | $45,148 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $47,657 | $36,996 | $93,816 | $48,668 |
| End Cash | $21,837 | $47,657 | $36,996 | $93,816 |
| Free Cash Flow | -$25,804 | -$23,113 | -$57,275 | -$78,091 |